Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD⁺

References

• Affer M, Chesi M, Chen WG, Keats JJ, Demchenko YN, Roschke AV, Van Wier S, Fonseca R, Bergsagel PL, Kuehl WM. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia. 2014;28:1725–35. doi:10.1038/leu.2014.70. PMID:24518206.
   PubMed Web of Science ®Google Scholar
• Boyd KD, Ross FM, Walker BA, Wardell CP, Tapper WJ, Chiecchio L, Dagrada G, Konn ZJ, Gregory WM, Jackson GH, et al. Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival. Clin Cancer Res. 2011;17:7776–84. doi:10.1158/1078-0432.CCR-11-1791. PMID:21994415.
   PubMed Web of Science ®Google Scholar
• Chesi M, Matthews GM, Garbitt VM, Palmer SE, Shortt J, Lefebure M, Stewart AK, Johnstone RW, Bergsagel PL. Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy. Blood. 2012;120:376–85. doi:10.1182/blood-2012-02-412783. PMID:22451422.
   PubMed Web of Science ®Google Scholar
• Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ, Colby CL 3rd, Therneau TM, Clark R, Kumar SK, Bradwell A, et al. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet. 2010;375:1721–8. doi:10.1016/S0140-6736(10)60482-5. PMID:20472173.
   PubMed Web of Science ®Google Scholar
• Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood. 1989;73:517–26. PMID:2783861.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, et al. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood. 2011;117:211–20. doi:10.1182/blood-2010-07-298349. PMID:20974671.
   PubMed Web of Science ®Google Scholar
• Mikhael JR, Dingli D, Roy V, Reeder CB, Buadi FK, Hayman SR, Dispenzieri A, Fonseca R, Sher T, Kyle RA, et al. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo. Clin Proc. 2013;88:360–76. doi:10.1016/j.mayocp.2013.01.019.
   Google Scholar
• Rajkumar SV, Leong T, Roche PC, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Kyle RA, Gertz MA, et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res. 2000;6:3111–6. PMID:10955791.
   PubMed Web of Science ®Google Scholar
• Horenstein AL, Quarona V, Toscani D, Costa F, Chillemi A, Pistoia V, Giuliani N, Malavasi F. Adenosine generated in the bone marrow niche through a CD38-mediated pathway correlates with progression of human myeloma. Mol Med. 2016;22. doi:10.2119/molmed.2016.00198. PMID:27761584.
   PubMed Web of Science ®Google Scholar
• Antonioli L, Pacher P, Vizi ES, Hasko G. CD39 and CD73 in immunity and inflammation. Trends Mol Med. 2013;19:355–67. doi:10.1016/j.molmed.2013.03.005. PMID:23601906.
   PubMed Web of Science ®Google Scholar
• Quarona V, Ferri V, Chillemi A, Bolzoni M, Mancini C, Zaccarello G, Roato I, Morandi F, Marimpietri D, Faccani G, et al. Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche. Ann N Y Acad Sci. 2015;1335:10–22. doi:10.1111/nyas.12485. PMID:25048519.
   PubMed Web of Science ®Google Scholar
• Horenstein AL, Chillemi A, Quarona V, Zito A, Roato I, Morandi F, Marimpietri D, Bolzoni M, Toscani D, Oldham RJ, et al. NAD(+)-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma Model. Cells. 2015;4:520–37. doi:10.3390/cells4030520. PMID:26393653.
   PubMed Web of Science ®Google Scholar
• Fedele G, Sanseverino I, D'Agostino K, Schiavoni I, Locht C, Horenstein AL, Malavasi F, Ausiello CM. Unconventional, adenosine-producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine. J Leukoc Biol. 2015;98:631–9. doi:10.1189/jlb.3A0315-101R. PMID:26089537.
   PubMed Web of Science ®Google Scholar
• Horenstein AL, Chillemi A, Zaccarello G, Bruzzone S, Quarona V, Zito A, Serra S, Malavasi F. A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes. Oncoimmunology. 2013;2:e26246. doi:10.4161/onci.26246. PMID:24319640.
   PubMed Web of Science ®Google Scholar
• Karakasheva TA, Waldron TJ, Eruslanov E, Kim SB, Lee JS, O'Brien S, Hicks PD, Basu D, Singhal S, Malavasi F, et al. CD38-Expressing myeloid-derived suppressor cells promote tumor growth in a murine model of esophageal cancer. Cancer Res. 2015;75:4074–85. doi:10.1158/0008-5472.CAN-14-3639. PMID:26294209.
   PubMed Web of Science ®Google Scholar
• Yu L, Huang Z, Mariani J, Wang Y, Moskowitz M, Chen JF. Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat Med. 2004;10:1081–7. doi:10.1038/nm1103. PMID:15448683.
   PubMed Web of Science ®Google Scholar
• Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B, László V, Pállinger E, Pap E, Kittel A, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68:2667–88. doi:10.1007/s00018-011-0689-3. PMID:21560073.
   PubMed Web of Science ®Google Scholar
• Kawamoto T, Ohga N, Akiyama K, Hirata N, Kitahara S, Maishi N, Osawa T, Yamamoto K, Kondoh M, Shindoh M, et al. Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis. PLoS One. 2012;7:e34045. doi:10.1371/journal.pone.0034045. PMID:22479517.
   PubMed Web of Science ®Google Scholar
• Boyiadzis M, Whiteside TL. The emerging roles of tumor-derived exosomes in hematological malignancies. Leukemia. 2017;31:1259–68. doi:10.1038/leu.2017.91. PMID:28321122.
   PubMed Web of Science ®Google Scholar
• Feng Q, Zhang C, Lum D, Druso JE, Blank B, Wilson KF, Welm A, Antonyak MA, Cerione RA, et al. A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis. Nat Commun. 2017;8:14450. doi:10.1038/ncomms14450. PMID:28205552.
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Secreto CR, Knox TR, Ding W, Mukhopadhyay D, Kay NE. Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood. 2010;115:1755–64. doi:10.1182/blood-2009-09-242719. PMID:20018914.
   PubMed Web of Science ®Google Scholar
• De Luca L, D'Arena G, Simeon V, Trino S, Laurenzana I, Caivano A, La Rocca F, Villani O, Mansueto G, Deaglio S, et al. Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia. Leuk Lymphoma. 2017;58:1424–32. doi:10.1080/10428194.2016.1243790. PMID:27739922.
   PubMed Web of Science ®Google Scholar
• Zhao A, Kong F, Liu CJ, Yan G, Gao F, Guo H, Guo AY, Chen Z, Li Q. Tumor cell-derived microvesicles induced not epithelial-mesenchymal transition but apoptosis in human proximal tubular (HK-2) cells: implications for renal impairment in multiple myeloma. Int J Mol Sci. 2017;18:513. doi:10.3390/ijms18030513.
   Web of Science ®Google Scholar
• Arendt BK, Walters DK, Wu X, Tschumper RC, Jelinek DF. Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation. Oncotarget. 2014;5:5686–99. doi:10.18632/oncotarget.2159. PMID:25015330.
   PubMed Web of Science ®Google Scholar
• Lima LG, Chammas R, Monteiro RQ, Moreira ME, Barcinski MA. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett. 2009;283:168–75. doi:10.1016/j.canlet.2009.03.041. PMID:19401262.
   PubMed Web of Science ®Google Scholar
• Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:1121–32. PMID:9028933.
   PubMed Web of Science ®Google Scholar
• Kanada M, Bachmann MH, Hardy JW, Frimannson DO, Bronsart L, Wang A, Sylvester MD, Schmidt TL, Kaspar RL, Butte MJ, et al. Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci U S A. 2015;112:E1433–42. PMID:25713383.
   PubMed Web of Science ®Google Scholar
• Treps L, Perret R, Edmond S, Ricard D, Gavard J. Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles. J Extracell Vesicles. 2017;6:1359479. doi:10.1080/20013078.2017.1359479. PMID:28815003.
   PubMed Web of Science ®Google Scholar
• Razmkhah F, Soleimani M, Mehrabani D, Karimi MH, Amini Kafi-Abad S, Ramzi M, Iravani Saadi M, Kakoui J. Leukemia microvesicles affect healthy hematopoietic stem cells. Tumour Biol. 2017;39:1010428317692234. doi:10.1177/1010428317692234. PMID:28218044.
   PubMedGoogle Scholar
• Karlsson T, Lundholm M, Widmark A, Persson E. Tumor cell-derived exosomes from the prostate cancer cell line TRAMP-C1 impair osteoclast formation and differentiation. PLoS One. 2016;11:e0166284. doi:10.1371/journal.pone.0166284. PMID:27832183.
   PubMed Web of Science ®Google Scholar
• Zhang L, Valencia CA, Dong B, Chen M, Guan PJ, Pan L. Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions. J Hematol Oncol. 2015;8:14. doi:10.1186/s13045-015-0111-y. PMID:25885907.
   PubMed Web of Science ®Google Scholar
• Berchem G, Noman MZ, Bosseler M, Paggetti J, Baconnais S, Le Cam E, Nanbakhsh A, Moussay E, Mami-Chouaib F, Janji B, et al. Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-beta and miR23a transfer. Oncoimmunology. 2016;5:e1062968. doi:10.1080/2162402X.2015.1062968. PMID:27141372.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhu XJ, Zeng C, Wu PH, Wang HX, Chen ZC, Li QB. Microvesicles secreted from human multiple myeloma cells promote angiogenesis. Acta Pharmacol Sin. 2014;35:230–8. doi:10.1038/aps.2013.141. PMID:24374814.
   PubMed Web of Science ®Google Scholar
• Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol. 2011;187:676–83. doi:10.4049/jimmunol.1003884. PMID:21677139.
   PubMed Web of Science ®Google Scholar
• Schuler PJ, Saze Z, Hong CS, Muller L, Gillespie DG, Cheng D, Harasymczuk M, Mandapathil M, Lang S, Jackson EK, et al. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol. 2014;177:531–43. doi:10.1111/cei.12354. PMID:24749746.
   PubMed Web of Science ®Google Scholar
• Muller L, Mitsuhashi M, Simms P, Gooding WE, Whiteside TL. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci Rep. 2016;6:20254. doi:10.1038/srep20254. PMID:26842680.
   PubMed Web of Science ®Google Scholar
• Zumaquero E, Munoz P, Cobo M, Lucena G, Pavon EJ, Martin A, Navarro P, García-Pérez A, Ariza-Veguillas A, Malavasi F, et al. Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70 and Lyn. Exp Cell Res. 2010;316:2692–706. doi:10.1016/j.yexcr.2010.05.032. PMID:20570673.
   PubMed Web of Science ®Google Scholar
• Henao Agudelo JS, Braga TT, Amano MT, Cenedeze MA, Cavinato RA, Peixoto-Santos AR, Muscará MN, Teixeira SA, Cruz MC, Castoldi A, et al. Mesenchymal stromal cell-derived microvesicles regulate an internal pro-inflammatory program in activated macrophages. Front Immunol. 2017;8:881. doi:10.3389/fimmu.2017.00881. PMID:28824619.
   PubMedGoogle Scholar
• Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, D'Souza-Schorey C. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009;19:1875–85. doi:10.1016/j.cub.2009.09.059. PMID:19896381.
   PubMed Web of Science ®Google Scholar
• Cieślak M, Komoszyński M, Wojtczak A. Adenosine A(2A) receptors in Parkinson's disease treatment. Purinergic Signalling. 2008;4:305–12. doi:10.1007/s11302-008-9100-8. PMID:18438720.
   PubMed Web of Science ®Google Scholar
• Ohta A, Sitkovsky M. The adenosinergic immuno-modulatory drugs. Current opinion in pharmacology. 2009;9:501–6. doi:10.1016/j.coph.2009.05.005. PMID:19539527.
   PubMed Web of Science ®Google Scholar
• Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol. 2001;41:775–87. doi:10.1146/annurev.pharmtox.41.1.775. PMID:11264476.
   PubMed Web of Science ®Google Scholar
• Chillemi A, Quarona V, Antonioli L, Ferrari D, Horenstein AL, Malavasi F. Roles and modalities of ectonucleotidases in remodeling the multiple myeloma niche. Front Immunol. 2017;8:305. doi:10.3389/fimmu.2017.00305. PMID:28373875.
   PubMed Web of Science ®Google Scholar
• van de Donk N, Richardson PG, Malavasi F. CD38 antibodies in multiple myeloma: back to the future. Blood. 2018;4:13–29. doi:10.1182/blood2017-06-740944. Epub 2017 Nov 8.
   PubMedGoogle Scholar
• Malavasi F, Chillemi A, Castella B, Schiavoni I, Incarnato D, Oliva S, et al. CD38 and Antibody Therapy: What Can Basic Science Add? Blood. 2016;128:SCI-36–SCI-.
   Google Scholar
• Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos M-V, Kumar S, Hillengass J, Kastritis E, Richardson P, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15:e538–e48. doi:10.1016/S1470-2045(14)70442-5. PMID:25439696.
   PubMed Web of Science ®Google Scholar
• Ferretti E, Tripodo C, Pagnan G, Guarnotta C, Marimpietri D, Corrias MV, Ribatti D, Zupo S, Fraternali-Orcioni G, Ravetti JL, et al. The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma. Leukemia. 2015;29:958–67. doi:10.1038/leu.2014.291. PMID:25283844.
   PubMed Web of Science ®Google Scholar
• Marimpietri D, Petretto A, Raffaghello L, Pezzolo A, Gagliani C, Tacchetti C, Mauri P, Melioli G, Pistoia V. Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. PLoS One. 2013;8:e75054. doi:10.1371/journal.pone.0075054. PMID:24069378.
   PubMed Web of Science ®Google Scholar
• Morandi F, Morandi B, Horenstein AL, Chillemi A, Quarona V, Zaccarello G, Carrega P, Ferlazzo G, Mingari MC, Moretta L, et al. A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation. Oncotarget. 2015;6:25602–18. doi:10.18632/oncotarget.4693. PMID:26329660.
   PubMedGoogle Scholar